RecruitingNot ApplicableNCT06358547

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years - a Randomized Controlled Multicenter Trial

Sponsor

Rigshospitalet, Denmark

Enrollment

590 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Infertility

Summary

A multinational multi-centre, randomized, controlled non-blinded trial with participation of three fertility clinics in Denmark and one in Spain to assess the efficacy and safety of preimplantation genetic testing for aneuploidy (PGT-A) in 37-41-year-old women.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 41 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying PGT-A for people with infertility. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 41 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPGT-A

PGT-A is a technique that allows for the prediction of embryo ploidy status through analysis of a trophectoderm biopsy conducted prior to embryo transfer.